Síndrome de Wünderlich: a propósito de un caso

Egileak

  • D. Barberá Pérez Centro de Salud. Sabiñán. Zaragoza. España.
  • N. Frías Aznar Centro de Salud Miralbueno. Zaragoza. España.
  • L. Pérez Pérez Laencina Centro de Salud Delicias Norte. Zaragoza. España.

##plugins.pubIds.doi.readerDisplayName##:

https://doi.org/10.23938/ASSN.0967

Gako-hitzak:

Hemoperitoneo, Angiomiolipoma

Laburpena

.

##plugins.generic.usageStats.downloads##

##plugins.generic.usageStats.noStats##

Erreferentziak

AHN T, ROBERTS MJ, NAVARATNAM A, CHUNG E, WOOD S. Changing etiology and management patterns for spontaneous renal hemorrhage: a systematic review of contemporary series. Int Urol Nephrol 2017; 49: 1897-1905. https://doi.org/10.1007/s11255-017-1694-8

AHMAD M, ARORA M, REDDU R, RIZVI I. Wunderlich's syndrome (spontaneous renal haemorrhage). BMJ Case Rep 2012; 2012: bcr2012006280. https://doi.org/10.1136/bcr-2012-006280

BHATT JR, RICHARD PO, KIM NS, FINELLI A, MANICKAVACHAGAM K, LEGERE L et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4 cm can be offered active surveillance as an initial management strategy. Eur Urol 2016; 70: 85-90. https://doi.org/10.1016/j.eururo.2016.01.048

SIMKINS A, MAITI A, CHERIAN SV. Wunderlich syndrome. Am. J. Med 2017; 130: 217-218. https://doi.org/10.1016/j.amjmed.2016.11.031

FERNÁNDEZ-PELLO S, HORA M, KUUSK T, TAHBAZ R, DABESTANI S, ABU-GHANEM Y et al. Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel. Eur Urol Oncol 2020; 3: 57-72. https://doi.org/10.1016/j.euo.2019.04.005

SWÄRD J, HENRIKSON O, LYRDAL D, PEEKER R, LUNDSTAM S. Renal angiomyolipoma-patient characteristics and treatment with focus on active surveillance. Scand J Urol 2020; 54: 141-146. https://doi.org/10.1080/21681805.2020.1716066

Argitaratuta

2021-08-20

Zenbakia

Atala

Cartas al editor